Engaging Novel Cell Types, Protein Targets and Efficacy Biomarkers in the Treatment of Diabetic Nephropathy
Saved in:
Main Authors: | Ryan M Fryer (Author), Carine M Boustany-Kari (Author), Scott M MacDonnell (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Biomarkers for the diagnosis of diabetic nephropathy
by: Marcio Concepción-Zavaleta, et al.
Published: (2024) -
PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
by: Stephen eOrena, et al.
Published: (2013) -
Serum fatty acid-binding protein 4 as a biomarker for early detection of diabetic nephropathy in type 2 diabetes
by: Amr M. Shaker, et al.
Published: (2023) -
Twenty-three accounts of reproductive injustice in Canada: Stories for nurses to know
by: Margaret Lebold, et al.
Published: (2022) -
A critical feminist discursive analysis of dynamics shaping abortion in Canada: Implications for nursing.
by: Margaret Lebold, et al.
Published: (2020)